US 12227746
Compounds and methods for modulating SCN2A
granted A61PA61P25/00
Quick answer
US patent 12227746 (Compounds and methods for modulating SCN2A) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P25/00